Eisai’s Approach To the New Alzheimer’s Drug
![drug manufacture](/sites/g/files/oketem336/files/styles/3_2_480x320/public/media/images/Depositphotos_443201908_manufacturing-durgs.jpg.webp?itok=tunKZujT)
Financial Times interviewed Dr. Keith Vossel about his perceptions of treating Alzheimer’s patients with lecanemab.
Financial Times interviewed Dr. Keith Vossel about his perceptions of treating Alzheimer’s patients with lecanemab.